Login

Ownership

13F as of Q2 2026 · 55.4M shares outstanding

Who owns Omega Therapeutics, Inc.?

By type of holder
Institutions 0.0% Everyone else 100.0%

No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".

Concentration Top 10 holders own 182.4%
Noubar Afeyan 52.8% · Flagship Pioneering, Inc. 40.2%
Institutional ownership
0.0%
0.0 pts vs last qtr
Institutional holders
1
0 vs last qtr
Net shares bought
0
by institutions in Q2 2026
New / sold out
0 / 0
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Omega Therapeutics, Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2021–FY2023
+141.1%
+55.27% a year
Each share's claim on the business
−58.5%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $19.7M
over 3 fiscal years
Diluted shares, split-adjusted
21.7M38.1M54.6M2021: 22.4M shares'212022: 47.9M shares'222023: 54.0M shares'23
Buybacks Stock-based comp
$0$4.4M$8.8M2021 buybacks: $02021 stock comp: $3.2M'212022 buybacks: $02022 stock comp: $7.8M'222023 buybacks: $02023 stock comp: $8.8M'23

How patient are the owners?

Institutional shares by how long they've been held
5+ years0% 3–5 years0% 1–3 years100% Under 1 year0%
Quarterly turnover
0.0%
of institutional shares changed hands
Top 10 managers, median time held
2.5 years

Super Investors

Investment managers reporting Omega Therapeutics, Inc. on Form 13F
HN
Huntington National Bank
Shares
1
% of company
0.00%
Change vs last qtr
Unchanged
Held since
2023

Institutional Funds

Mutual funds and ETFs reporting Omega Therapeutics, Inc. on Form N-PORT; together they hold 2.2% of the company
VT
Position value
$581K
% of company
1.41%
% of the fund
0.00%
As of
December 31, 2024
VE
Position value
$231K
% of company
0.56%
% of the fund
0.00%
As of
December 31, 2024

6 more funds behind a free account

See every fund holding Omega Therapeutics, Inc. and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
NA
Noubar Afeyan
5%+ holder13D · 52.8%
Shares
29.2M
% of company
52.79%
Change vs last qtr
—
Held since
—
FP
Flagship Pioneering, Inc.
5%+ holder13D · 40.2%
Shares
22.2M
% of company
40.17%
Change vs last qtr
—
Held since
—

15 more holders behind a free account

See every insider and 5%+ holder of Omega Therapeutics, Inc..

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support